IPO Listed — 30 Mar 2026
Listing Price: ₹124 (+0% vs ₹124)
Speciality Medicines SME IPO Review
Speciality Medicines SME IPO has been reviewed by 1 analyst, and the overall consensus is Strong Apply — carrying a score of 100. Out of the 1 analysts who have covered this IPO, 1 recommend subscribing — reflecting a mixed view from the analyst community.
The issue is priced in the band of ₹117-124 per share , with a minimum application size of 1000 shares (minimum investment of approximately ₹124,000 at the upper band) . Subscription ran from 20 Mar 2026 to 24 Mar 2026. Scroll down for the full analyst breakdown and analyst-wise verdicts.
Table of Contents
Recommend Subscribe
Based on 1 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Speciality Medicines SME IPO?
Based on analyst coverage tracked on this page, the overall verdict for Speciality Medicines SME IPO is Strong Apply. Out of 1 analyst who have reviewed this IPO, 1 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 100 mean for Speciality Medicines SME IPO?
The score of 100 is an aggregate of all analyst ratings tracked for Speciality Medicines SME IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.
What was the actual listing price of Speciality Medicines SME IPO?
Speciality Medicines SME IPO listed on March 30, 2026 at ₹124 , against the issue price of ₹124 — a gain of +0% (₹0 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Speciality Medicines SME IPO?
Speciality Medicines SME IPO was priced at ₹117-124 per share. The minimum lot size is 1000 shares, making the minimum investment approximately ₹124,000 at the upper end of the price band. Subscription ran from 20 Mar 2026 to 24 Mar 2026.
Explore Speciality Medicines SME IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!